Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Income from Continuing Operations (2021 - 2023)

Updated

Nika Pharmaceuticals' Income from Continuing Operations came in at -$10,143 for Q3 2023, compared with -$6,339 a year earlier.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Income from Continuing Operations (2021 - 2023) Analysis & Trends

Over the trailing twelve months to Sep 30, 2023, Nika Pharmaceuticals reported Income from Continuing Operations of -$72,569; for FY2022, it was -$3.18 million.

  • Going back by year, Income from Continuing Operations was -$14,712 in FY2021.
  • The five-year range for quarterly Income from Continuing Operations is -$3.16 million (Q2 2022) to $6,316 (Q1 2022).
  • Business Quant data shows NIKA's Income from Continuing Operations at -$27,806 (Q2 2023), -$19,570 (Q1 2023) and -$15,050 (Q4 2022) in the three quarters before Q3 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -10,143.00
Jun 30, 2023 -27,806.00
Mar 31, 2023 -19,570.00
Dec 31, 2022 -15,050.00
Sep 30, 2022 -6,339.00
Jun 30, 2022 -3.16 Mn
Mar 31, 2022 6,316.00
Dec 31, 2021 -26,124.00
Sep 30, 2021 2,699.00
Jun 30, 2021 2,959.00
Mar 31, 2021 -5,754.00
API Access

Nika Pharmaceuticals, Inc Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=NIKA&period=max&api_key=YOUR_API_KEY